Merle Griff, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Merle Griff, Ph.D.
Earlier roles on record: CEO at AnTix Holdings, Inc. (IMTH) until April 18, 2024. AnTix Holdings, Inc. reported in an 8-K filed April 22, 2024 that Merle Griff, Ph.D. was terminated as CEO, effective April 18, 2024.
“On April 18, 2024, Innovative MedTech, Inc. (the "Company") terminated Merle Griff, PhD., as the Company's CEO, and Michael Friedman, the Company's President and CFO, was appointed as CEO of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2022-05-24–2024-04-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.